The dependence of cancers with BRCA1/BRCA2 mutations or other HRR defects on poly[adenosine diphosphate (ADP)-ribose] polymerase (PARP) enzymes to correct DSBs leads to apoptosis in the presence of PARPi [35]. Here, PARP1 is linked to cancer.